Ownership history in Global Alpha Capital Management Ltd. Β· 36 quarters on record
This page tracks every 13F SEC filing in which Global Alpha Capital Management Ltd. reported a position in Globus Medical A (GMED). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π Global Alpha Capital Management Ltd. outperformed the S&P 500 by +2.0% annually on this GMED position. Timing score: 57% (20/35 decisions correct). Average cost basis: $54.29. Maximum drawdown during holding period: β36.0%.
β
Outperformed SPY on this position by 2.0% ann.
11 quarters analyzed
β
Decent timing β more right than wrong on entries and exits.
20 of 35 add/trim decisions correct
Best entry: $29.62 (2017 Q1) Β· Worst: $77.53 (2021 Q2)
πͺ Held through 5 major drawdowns (>20%). Diamond-hands conviction.
23 adds Β· 13 trims. Bought during 6 of 13 down-price quarters. π More buys than sells across the holding period.
π Portfolio weight has been declining in recent quarters. Possible distribution phase.
Currently 3.55% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size